CEST MRI monitoring of tumor response to vascular disrupting therapy using high molecular weight dextrans.
Hanwei ChenDexiang LiuYuguo LiXiang XuJiadi XuNirbhay N YadavShibin ZhouPeter C M van ZijlGuanshu LiuPublished in: Magnetic resonance in medicine (2019)
High molecular weight dextrans can be used as safe and sensitive CEST MRI contrast agents for monitoring tumor response to vascular disrupting therapy and, potentially, for developing dextran-based theranostic drug delivery systems.